Precisely quantifying SUI severity and sling tension
This article was originally published in Start Up
NexHand Inc. has developed proprietary, sensor-based "smart surgical glove" technology designed to enable physicians to assess the severity of stress urinary incontinence. Its technology has been developed into two disposable products: the first is a noninvasive diagnostic tool for assessing the severity of SUI in the clinical setting, the UroGlove, and the second is a probe-based sensor for determining proper tensioning of urethral slings during surgery.
You may also be interested in...
Angel- and venture-backed medtech start-ups are working to fill the tremendous unmet need for alternative device options for treating (not just managing) female urinary incontinence a condition that has a significant impact on quality of life for millions of women. In this issue we profile Floelle, InControl Medical, NexHand, and Solace Therapeutics.
Federal law requiring agencies to weigh and document potential environmental impacts of major regulatory actions does not dictate what happens next. Neither does it provide federal agencies with authorities beyond their statutory purviews, FDA/CDER leadership says.
The European Medicines Agency has reported progress with a collaborative project that involves other regulators in its assessments of COVID-19 products, and with the EU Medicines for All initiative for evaluating products for non-EU markets.